MD Revenue Group provides specialized, high-performance revenue cycle management for independent dermatology practices, multi-site medical dermatology groups, and specialized Mohs surgical centers. We eliminate "Clinical Leakage" by mastering the complex 2026 shifts in Mohs micrographic surgery coding, lesion destruction bundling, and high-cost biologic medication authorizations. Our Medical Billing Services are engineered to transform your high-volume dermatology practice into a proactive financial environment where "Surface Value" is never lost to administrative friction.
Claim Free Dermatology AuditFor an independent dermatology physician, the choice to outsource RCM isn't about giving up control—it's about gaining technical leverage against aggressive payers. Our Medical Billing Services provide the administrative backbone required to allow your dermatologists to focus on patient outcomes rather than insurance friction.
As you add new physicians, specialized Mohs surgeons, or specialized cosmetic-only mid-levels, your billing scales instantly without the need for additional Credentialing staff or office space.
By catching technical and anatomical errors (like Payer Enrollment gaps or expired facility links) *before* submission, we dramatically accelerate your cash flow for clinical growth.
We build "Audit-Armor" into the foundation of your dermatology practice. Our experts ensure that every lesion log, every biopsy note, and every biologic authorization is "Ready for Scrutiny" before it ever leaves your office.
Dermatology is a specialty defined by high procedure volume and the extreme technicality of "Same-Day" encounter logic. In 2026, the administrative friction for dermatological care has reached an all-time high, with payers using advanced AI-algorithms to audit "Biopsy-to-Treatment" conversions and the medical necessity of high-frequency destructions.
A primary source of revenue erosion for dermatology practices is the failure to properly append **Modifier -25** to E/M visits when a biopsy or minor procedure is performed on the same day. In 2026, many payers have automated cross-referencing for same-day encounters. If the clinical note doesn't explicitly justify the "Separately Identifiable" nature of the evaluation, the office visit is auto-deleted. We implement Revenue Integrity protocols to ensure every distinct clinical encounter is accurately remunerated.
Payers frequently deny Mohs surgery claims (17311–17315) when the number of stages and blocks documented in the narrative doesn't precisely match the units billed. In 2026, if the "Surgical Mapping" doesn't satisfy technical requirements, the whole claim is auto-denied or downcoded to a simple excision. MDRG’s Revenue Cycle Management experts specialize in technical reconciliation to avoid these automatic denials.
Dermatology practices that prescribe high-cost biologics (for psoriasis or atopic dermatitis) often lose money due to "Prior Auth" failures and incorrect J-code synchronization. In 2026, payers require absolute precision in documenting the "Failed Therapy" history before authorizing high-cost drugs. Without this, the practice absorbs the administrative cost of the medication workup.
Topical authority in dermatology RCM involves mastering the 10000-series CPT codes and the nuances of high-complexity skin destruction. Our dermatology-certified coders ensure every Revenue Cycle Management submission is optimized for technical success.
Mod -25 and Same-day conversion logic
Proper lesion-count documentation
Technical vs. Professional component splits
Closure (Simple/Intermediate) bundling
Anatomic-specific closure documentation
Medical necessity for specialized skin care
Defending evaluation parity
In 2026, dermatology billing is a battle of "Anatomical Documentation." Payers are no longer just looking for coding errors; they are using AI-driven auditing to challenge the *decisions* made on the exam table. We defend your revenue against these three high-frequency rejection types:
Payer bots often deny a same-day E/M visit if the chart doesn't explicitly state that the evaluation was "Distinct and Significant" from the procedure. If the biopsy was "routine," the office visit is bundled.
Many payers have updated their 2026 audit triggers for destruction codes (17000-series). If the chart doesn't list the *exact* anatomical location of every lesion destroyed, most billers face an automatic technical rejection or downcoding.
For newer specialized skin biologics or advanced phototherapy treatments, payers often trigger "Experimental" denials even for FDA-cleared hardware.
In 2026, the key to dermatology revenue is the "Anatomical Narrative." We help your providers implement "Audit-Armor" charting strategies that signal authority to payer algorithms. This includes using "Trigger Phrases" for surgical setting necessity and automating the capture of specialized biologic-auth data.
We help you structure your biopsy reports so that the "Technical Necessity" of a separately identifiable encounter is undeniable to even the most aggressive automated payer bots.
We teach your team how to describe lesion management in a way that reflects the true "Sequential Intensity" of the work, reducing the risk of automated downcoding.
MDRG acts as your practice’s "Clinical-to-Financial Bridge." We focus entirely on Revenue Cycle Management efficiency so you can focus on clinical diagnostics and aesthetic care.
We synchronize with your EHR (EMA/Modernizing Medicine, Nextech, EZDerm, etc.) to establish a clean, high-speed data bridge.
Every dermatology claim is scrubbed for 2026 CPT/Diagnosis parity before it hits the clearinghouse. We look for "Modifier-25 Red-Flags" that AI-payers use to auto-delete high-value same-day office visits.
We don't accept "No." We challenge every technical surgical and diagnostic denial with clinical precision, leveraging our dermatology-certified coders to file high-level appeals for your most complex cases.
Track your net collections, "Per-Procedure Yield," and payer performance points with total transparency via our secure client portal.
To defend your dermatology revenue in 2026, your procedure records must be bulletproof. We provide our dermatology clients with a rigorous documentation checklist to ensure compliance:
In a technical audit for a 8-physician multi-site dermatology group in the Sunbelt, MDRG identified a $192,000 annual revenue leakage in their same-day biopsy and Mohs surgical billing. The group was failing to correctly apply Modifier -25 for diagnostic evaluations and was losing the technical value of their second-stage Mohs blocks.
By implementing Revenue Cycle Management best practices—including real-time "Modifier-Capture Training" for their clinical staff—MDRG was able to: * **Recover $122,000 in uncaptured E/M and Mohs revenue** within the first 6 months. * **Reduce their "Global-Mismatch" Denial Rate** by 68% using specialized anatomical narratives. * **Accelerate Cash Flow** by reducing their average days in A/R from 44 days to 22 days.
This dermatology group now operates with "Audit-Armor" protection, knowing that every high-value lesion treatment is protected from automated payer clawbacks.
In the high-intensity environment of 2026, your dermatology practice deserves a revenue cycle that is as precise as your clinical diagnostics. Don't let your "Surgical Value" be eroded by primitive billing and administrative friction.
Direct PDF download. We respect medical practice privacy.
Get a free audit of your billing. If we don't find money you're leaving on the table, you don't pay a dime.